Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1

被引:56
作者
Morgan, Matt [2 ]
Khan, David A. [1 ]
机构
[1] SW Texas State Univ, Div Allergy & immunol, Dallas, TX 75390 USA
[2] Allergy Asthma & Immunol N Texas, McKinney, TX USA
关键词
D O I
10.1016/S1081-1206(10)60462-0
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Objective: To evaluate the use of alternative therapies for chronic urticaria refractory to first-line treatments in an evidence-based manner. Data Sources: MEDLINE searches were performed cross-referencing urticaria with the names of multiple therapies. Articles were then reviewed for additional citations. Articles published after 1950 were considered. Study Selection: All articles, including case reports, were reviewed for soundness and relevance. Results: Experience has been reported for a wide variety of alternative therapies in the treatment of chronic idiopathic and physical urticarias. Evidence for most agents is limited to anecdotal reports. The second-line therapies reviewed are also categorized based on criteria of safety, efficacy, convenience, and cost, in relation to the first-line antihistamines. Conclusions: Alternative agents should be considered in patients with chronic urticaria who are both severely affected and unresponsive to antihistamines. Although monitoring for toxicity is important in management with many alternative agents, safety is favorable compared with corticosteroids.
引用
收藏
页码:403 / 411
页数:9
相关论文
共 101 条
[1]   Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses [J].
Asero, R. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (01) :34-38
[2]   Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria [J].
Asero, R .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2000, 85 (02) :156-157
[3]   Leukotriene receptor antagonists in chronic urticaria [J].
Asero, R ;
Tedeschi, A ;
Lorini, M .
ALLERGY, 2001, 56 (05) :456-457
[4]   THE NORMOCOMPLEMENTEMIC URTICARIAL VASCULITIS SYNDROME - REPORT OF A CASE AND RESPONSE TO COLCHICINE [J].
ASHERSON, RA ;
BUCHANAN, N ;
KENWRIGHT, S ;
FLETCHER, CM ;
HUGHES, GRV .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1991, 16 (06) :424-427
[5]   The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results [J].
Bagenstose, SE ;
Levin, L ;
Bernstein, JA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (01) :134-140
[6]  
BARLOW RJ, 1993, EUR J DERMATOL, V3, P273
[7]  
Baskan E Bulbul, 2004, J Dermatolog Treat, V15, P164
[8]   Leukotriene modifiers in chronic urticaria [J].
Bensch, G ;
Borish, L .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 83 (04) :348-348
[9]   Successful treatment of delayed pressure urticaria with montelukast [J].
Berkun, Y ;
Shalit, M .
ALLERGY, 2000, 55 (02) :203-204
[10]   VASCULAR EFFECTS OF LEUKOTRIENE-D4 IN HUMAN-SKIN [J].
BISGAARD, H .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 88 (02) :109-114